Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.
Authors:
- J Y BlayJBJ Y Blay
- D BranellecDBD Branellec
- E RobinetERE Robinet
- B DugasBDB Dugas
- F GayFGF Gay
- S ChouaïbSCS Chouaïb
Open Access
- 1 June 1990
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 85 (6) , 1909-1913
Abstract
In previous studies, IL-4 has been reported to interfere with IL-2-driven generation of lymphokine-activated killer (LAK) activity. In this investigation, we have demonstrated that IL-4 inhibited the IL-2-induced differentiation of large granular lymphocytes (LGL) into LAK effectors by a mechanism involving, at least in part, an increase in LGL intracellular cAMP levels. In contrast, with its capacity to induce cAMP accumulation in resting LGL, IL-4 had a very negligible effect on LAK activity induction, and cAMP levels increase in LGL that had been preincubated with IL-2. Furthermore, the inhibitory effect of IL-4 on LAK activity generation also correlated with a marked decrease in N-CBZ-L-lysine thiobenzylester esterase activity, with an inhibition of tumor necrosis factor (TNF) mRNA expression and TNF production by IL-2-stimulated LGL. These results strongly suggest that complex signaling processes could be ascribed to the dual activities of cytokines and their interplay in LAK promotion.Keywords
This publication has 26 references indexed in Scilit:
- Functional interactions of IL2 and TNF in the differentiation of LGL into lak effectorsInternational Journal of Cancer, 1989
- IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.The Journal of Immunology, 1989
- IL-2 induces expression of serine protease enzymes and genes in natural killer and nonspecific T killer cells.The Journal of Immunology, 1989
- Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.Proceedings of the National Academy of Sciences, 1989
- Inhibition of lymphokine-activated killer cell-mediated cytotoxicity by phorbol ester.The Journal of Immunology, 1989
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1.Proceedings of the National Academy of Sciences, 1988
- The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune responseImmunology Today, 1988
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980
- Human lymphocyte metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutininJournal of Clinical Investigation, 1971